AQR Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,838
| Closed | -$1.02M | – | 2330 |
|
|
2022
Q3 | $1.02M | Buy |
19,838
+11,064
| +126% | +$457K | ﹤0.01% | 1507 |
|
|
2022
Q2 | $217K | Buy |
+8,774
| New | +$193K | ﹤0.01% | 1975 |
|
|
2021
Q2 | – | Sell |
-29,527
| Closed | -$1.51M | – | 2322 |
|
|
2021
Q1 | $1.51M | Sell |
29,527
-1,020
| -3% | -$61.4K | ﹤0.01% | 1369 |
|
|
2020
Q4 | $1.89M | Sell |
30,547
-4,444
| -13% | -$254K | ﹤0.01% | 1194 |
|
|
2020
Q3 | $1.92M | Sell |
34,991
-6,383
| -15% | -$344K | ﹤0.01% | 1134 |
|
|
2020
Q2 | $2.38M | Sell |
41,374
-2,274
| -5% | -$124K | ﹤0.01% | 1083 |
|
|
2020
Q1 | $1.75M | Buy |
43,648
+38,036
| +678% | +$1.62M | ﹤0.01% | 1121 |
|
|
2019
Q4 | $222K | Buy |
+5,612
| New | +$98.5K | ﹤0.01% | 1985 |
|
|
2019
Q3 | – | Sell |
-13,606
| Closed | -$127K | – | 2193 |
|
|
2019
Q2 | $127K | Sell |
13,606
-8,758
| -39% | -$101K | ﹤0.01% | 2023 |
|
|
2019
Q1 | $311K | Hold |
22,364
| – | – | ﹤0.01% | 1959 |
|
|
2018
Q4 | $244K | Hold |
22,364
| – | – | ﹤0.01% | 2029 |
|
|
2018
Q3 | $283K | Hold |
22,364
| – | – | ﹤0.01% | 2121 |
|
|
2018
Q2 | $295K | Buy |
+22,364
| New | +$267K | ﹤0.01% | 2127 |
|
Other funds holding CCXI
AQR Capital Management's CCXI Position: Q4 2022 in Review
AQR Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 19,838 shares — an estimated $1.02M sold.
AQR Capital Management first reported a position in CCXI in Q2 2018 and held it in 13 quarters. The position peaked at $2.38M in Q2 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- AQR Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- AQR Capital Management sold 19,838 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.02M.
- AQR Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2018 and held it in 13 quarters.
- AQR Capital Management's ChemoCentryx, Inc. position peaked at $2.38M in Q2 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.